株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品有効成分 (API) の世界市場:収益・市場動向・成長率・市場シェアの分析・予測

Active Pharmaceutical Ingredient Market - Global Revenue, Trends, Growth, Share, Size and Forecast

発行 Scalar Market Research 商品コード 531385
出版日 ページ情報 英文 118 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.74円で換算しております。
医薬品有効成分 (API) の世界市場:収益・市場動向・成長率・市場シェアの分析・予測 Active Pharmaceutical Ingredient Market - Global Revenue, Trends, Growth, Share, Size and Forecast
出版日: 2016年12月01日 ページ情報: 英文 118 Pages
概要

当レポートでは、世界の医薬品有効成分 (API) の市場を調査し、市場の定義と概要、市場への各種影響因子および市場機会の分析、法規制環境、製造業者区分・合成区分・薬剤区分・原薬区分・治療領域・地域/主要国別の動向と市場規模の推移と予測、競合環境、企業プロファイルなどをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市場力学

  • 成長推進因子
  • 成長抑制因子
  • 市場機会
  • 市場動向

第4章 産業分析

  • 産業概要
  • 法規制分析

第5章 市場分析・予測:製造業者区分別

  • 市場シェア
  • 製造業者区分
    • 自社用
    • 商用

第6章 市場分析・予測:合成区分別

  • 市場シェア
  • 合成区分
    • 合成
    • 生物学的

第7章 市場分析・予測:薬剤区分別

  • 市場シェア
  • 薬剤区分
    • ジェネリック薬
    • ブランド薬

第8章 市場分析・予測:原薬区分別

  • 市場シェア
  • 原薬区分別
    • 高活性原薬 (HPAPI)
    • その他

第9章 市場分析・予測:治療領域別

  • 市場シェア
  • 治療領域
    • 心血管疾患
    • 代謝性疾患
    • CNS
    • 筋骨格疾患
    • NSAID
    • その他

第10章 市場分析・予測:地域別

  • 北米
    • 国別
      • 米国
      • カナダ
    • 製造業者区分別
    • 合成区分別
    • 薬剤区分別
    • 原薬区分別
    • 治療領域別
  • 欧州
    • 国別
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • その他
    • 製造業者区分別
    • 合成区分別
    • 薬剤区分別
    • 原薬区分別
    • 治療領域別
  • アジア太平洋
    • 国別
      • 中国
      • インド
      • ロシア
      • 日本
      • その他
    • 製造業者区分別
    • 合成区分別
    • 薬剤区分別
    • 原薬区分別
    • 治療領域別
  • その他の地域
    • 地域別
      • ラテンアメリカ
      • 中東・アフリカ
    • 製造業者区分別
    • 合成区分別
    • 薬剤区分別
    • 原薬区分別
    • 治療領域別

第11章 競合環境

  • 市場の位置付け

第12章 主要企業

  • Teva Pharmaceutical Ingredients Ltd.
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma Limited
  • Mylan N.V.
  • Sandoz (Novartis AG)
  • Cambrex Corporation
  • BoehringerIngelheim GmbH
  • Pfizer,Inc
  • Lonza Group

第13章 SCALARの全方位的展望

第14章 付録

目次
Product Code: HC167

Title:
Active Pharmaceutical Ingredient (API) Market
by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022Y.

Global Active Pharmaceutical Ingredients (API) Market worth USD 154.88 billion in 2016 and expected to reach USD 224.63 billion by 2022, at a CAGR of 6.4% from 2016 to 2022.

The global active pharmaceutical ingredients (API) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the active pharmaceutical ingredients (API) market.

KEY BENEFITS OF THE REPORT:

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS:

  • The advancements in biologics, increasing local manufacture, the rise in the aging population, and the increasing number of chronic disease are the major drivers for the active pharmaceutical ingredients (API) market.
  • The increasing awareness towards generic drugs, government initiatives, and better market penetration are some of the other factors that will boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.
  • However, the high cost of manufacturing, the regulatory norms, and financial instability are the major restraints for the global active pharmaceutical ingredients (API) market.

MARKET SEGMENTATION:

This report analyzes the active pharmaceutical ingredients (API) market by the following segments:

Active Pharmaceutical Ingredient (API) Market, by Manufacturer

  • Captive
  • Merchant

Active Pharmaceutical Ingredient (API) Market, by Synthesis

  • Synthetic
  • Biological

Active Pharmaceutical Ingredient (API) Market, by Drug Type

  • Generic
  • Branded

Active Pharmaceutical Ingredient (API) Market, by Classification

  • HPAPI
  • Others

Active Pharmaceutical Ingredient (API) Market, by Therapeutic Area

  • Cardiovascular Disorders
  • Metabolic Disorders
  • CNS
  • Oncology
  • Musculoskeletal Diseases
  • NSAIDs
  • Others

KEY MARKET PLAYERS:

Key players in the active pharmaceutical ingredients (API) market include:

  • Teva Pharmaceutical Industries, Ltd.
  • Sun Pharmaceutical Industries, Ltd.
  • Dr.Reddy's Laboratories
  • Aurobindo Pharma Ltd.
  • Mylan N.V.
  • Novartis AG
  • Cambrex Corporation
  • Boehringer Ingelheim GmbH
  • Pfizer, Inc.
  • Lonza Group

Table of Contents

1.MARKET OVERVIEW

  • 1.1.Definitions
  • 1.2.Research Methodology
    • 1.2.1.Primary Data
    • 1.2.2.Secondary Data
    • 1.2.3.Machine Learning
    • 1.2.4.Research Scope
    • 1.2.5.Years Considered
    • 1.2.6.Currency & Pricing
  • 1.3.Market Segmentation
  • 1.4.Key Objectives & Benefits of the Report
    • 1.4.1.Objectives of the Report
    • 1.4.2.Key Benefits of the Report

2.EXECUTIVE SUMMARY

3.MARKET DYNAMICS

  • 3.1.Drivers
  • 3.2.Restraints
  • 3.3.Opportunities
  • 3.4.Premium Industry Trends

4.INDUSTRY ANALYSIS

  • 4.1.Industry Overview
  • 4.2.Regulatory Analysis

5.ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BYMANUFACTURER

  • 5.1.Share Segmentation
  • 5.2.Manufacturer
    • 5.2.1.Captive
    • 5.2.2.Merchant

6.ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNTHESIS

  • 6.1.Share Segmentation
  • 6.2.Synthesis
    • 6.2.1.Synthetic
    • 6.2.2.Biological

7.ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY DRUG TYPE

  • 7.1.Share Segmentation
  • 7.2.Drug Type
    • 7.2.1.Generic
    • 7.2.2.Branded

8.ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY CLASSIFICATION

  • 8.1.Share Segmentation
  • 8.2.Classification
    • 8.2.1.HPAPI
    • 8.2.2.Others

9.ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY THERAPEUTIC AREA

  • 9.1.Share Segmentation
  • 9.2.Therapeutic Area
    • 9.2.1.Cardiovascular Disorders
    • 9.2.2.Metabolic Disorders
    • 9.2.3.CNS
    • 9.2.4.Oncology
    • 9.2.5.Musculoskeletal Diseases
    • 9.2.6.NSAIDs
    • 9.2.7.Other Diseases

10.ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY GEOGRAPHY

  • 10.1.North America
    • 10.1.1.By Regions
      • 10.1.1.1.U.S.
      • 10.1.1.2.Canada
    • 10.1.2.By Manufacturer
    • 10.1.3.By Synthesis
    • 10.1.4.By Drug Type
    • 10.1.5.By Classification
    • 10.1.6.By Therapeutic Area
  • 10.2.Europe
    • 10.2.1.By Regions
      • 10.2.1.1.Germany
      • 10.2.1.2.U.K
      • 10.2.1.3.France
      • 10.2.1.4.Italy
      • 10.2.1.5.Rest of Europe
    • 10.2.2.By Manufacturer
    • 10.2.3.By Synthesis
    • 10.2.4.By Drug Type
    • 10.2.5.By Classification
    • 10.2.6.By Therapeutic Area
  • 10.3.Asia-Pacific
    • 10.3.1.By Regions
      • 10.3.1.1.China
      • 10.3.1.2.India
      • 10.3.1.3.Russia
      • 10.3.1.4.Japan
      • 10.3.1.5.Rest of Asia-Pacific
    • 10.3.2.By Manufacturer
    • 10.3.3.By Synthesis
    • 10.3.4.By Drug Type
    • 10.3.5.By Classification
    • 10.3.6.By Therapeutic Area
  • 10.4.Rest of the World (ROW)
    • 10.4.1.By Regions
      • 10.4.1.1.Latin America
      • 10.4.1.2.Middle East & Africa
    • 10.4.2.By Manufacturer
    • 10.4.3.By Synthesis
    • 10.4.4.By Drug Type
    • 10.4.5.By Classification
    • 10.4.6.By Therapeutic Area

11.COMPETITIVE LANDSCAPE

  • 11.1.Market Positioning

12.KEY MARKET PLAYERS

  • 12.1.Teva Pharmaceutical Ingredients Ltd.
    • 12.1.1.Overview
    • 12.1.2.Key Strategies
      • 12.1.2.1.Strategic Partnerships and Collaborations
      • 12.1.2.2.Focus on key growth market areas
      • 12.1.2.3.Solidifying leadership position in core therapeutic areas
      • 12.1.2.4.Focus on generic business transformation
    • 12.1.3.Recent Developments
  • 12.2.Sun Pharmaceutical Industries Limited
    • 12.2.1.Overview
    • 12.2.2.Key Strategies
      • 12.2.2.1.Product Innovation
    • 12.2.3.Recent Developments
  • 12.3.Dr. Reddy's Laboratories
    • 12.3.1.Overview
    • 12.3.2.Key Strategies
      • 12.3.2.1.Product Innovation
    • 12.3.3.Recent Developments
  • 12.4.Aurobindo Pharma Limited
    • 12.4.1.Overview
    • 12.4.2.Key Strategies
      • 12.4.2.1.Strategic Acquisitions and Collaboration
    • 12.4.3.Recent Developments
  • 12.5.Mylan N.V.
    • 12.5.1.Overview
    • 12.5.2.Key Strategies
      • 12.5.2.1.Strategic Acquisitions
      • 12.5.2.2.Product Diversification
    • 12.5.3.Recent Developments
  • 12.6.Sandoz (Novartis AG)
    • 12.6.1.Overview
    • 12.6.2.Key Strategies
      • 12.6.2.1.Technological Innovation
    • 12.6.3.Recent Developments
  • 12.7.Cambrex Corporation
    • 12.7.1.Overview
    • 12.7.2.Key Strategies
      • 12.7.2.1.Product Innovation
    • 12.7.3.Recent Developments
  • 12.8.BoehringerIngelheim GmbH
    • 12.8.1.Overview
    • 12.8.2.Key Strategy
      • 12.8.2.1.Focus on research & development
    • 12.8.3.Recent Developments
  • 12.9.Pfizer,Inc
    • 12.9.1.Overview
    • 12.9.2.Key Strategies
      • 12.9.2.1.Focus on Strategic Acquisitions, Collaborations, and Partnerships
    • 12.9.3.Recent Developments
  • 12.10.Lonza Group
    • 12.10.1.Overview
    • 12.10.2.Key Strategies
      • 12.10.2.1.Focus on Business Expansion
    • 12.10.3.Recent Developments

13.SCALAR 360 DEGREE MARKET PERSPECTIVE

14.APPENDIX

  • 14.1.Related Reports

LIST OF TABLES

  • Table 1. Global Active Pharmaceutical Ingredient Market Summary
  • Table 2. Global Active Pharmaceutical Ingredients Market Drivers
  • Table 3. Global Active Pharmaceutical Ingredient Market Restraints
  • Table 4. Application of Guidance to API Manufacturing
  • Table 5. Active Pharmaceutical Ingredient Market, By Manufacturer Snapshot
  • Table 6. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Manufacturer (2014 - 2022)
  • Table 7. Global Captive API Market Size (US$ billion),By Regions (2014 - 2022)
  • Table 8. Global Merchant API Market Size (US$ billion),By Regions (2014 - 2022)
  • Table 9. Active Pharmaceutical Ingredient Market, By Synthesis Snapshot
  • Table 10. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Synthesis (2014 - 2022)
  • Table 11. Global Active Pharmaceutical Ingredient Market for Synthetic, Market Size (US$ billion) (2014 - 2022)
  • Table 12. Global Active Pharmaceutical Ingredient Market for Biological, Market Size (US$ billion) (2014 - 2022)
  • Table 13. Active Pharmaceutical Ingredient Market, By Drug Type Snapshot
  • Table 14. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Drug Type (2014 - 2022)
  • Table 15. Global Active Pharmaceutical Ingredient Market for Generics, Market Size (US$ billion) (2014 - 2022)
  • Table 16. Global Active Pharmaceutical Ingredient Market for Branded, Market Size (US$ billion) (2014 - 2022)
  • Table 17. Active Pharmaceutical Ingredient Market, By Classification Snapshot
  • Table 18. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Classification (2014 - 2022)
  • Table 19. Global HPAPI Market , Market Size (US$ billion) (2014 - 2022)
  • Table 20. Global Active Pharmaceutical Ingredient Market for Other Classification, Market Size (US$ billion) (2014 - 2022)
  • Table 21. Active Pharmaceutical Ingredient Market, By Therapeutic Area Snapshot
  • Table 22. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Therapeutic Area (2014 - 2022)
  • Table 23. Global Active Pharmaceutical Ingredient Market for Cardiovascular Disorders, Market Size (US$ billion) (2014 - 2022)
  • Table 24. Global Active Pharmaceutical Ingredient Market for Metabolic Disorders, Market Size (US$ billion) (2014 - 2022)
  • Table 25. Global Active Pharmaceutical Ingredient Market for CNS, Market Size (US$ billion) (2014 - 2022)
  • Table 26. Global Active Pharmaceutical Ingredient Market for Oncology, Market Size (US$ billion) (2014 - 2022)
  • Table 27. Global Active Pharmaceutical Ingredient Market for Musculoskeletal Diseases, Market Size (US$ billion) (2014 - 2022)
  • Table 28. Global Active Pharmaceutical Ingredient Market for NSAIDs, Market Size (US$ billion) (2014 - 2022)
  • Table 29. Global Active Pharmaceutical Ingredient Market for Other Diseases, Market Size (US$ billion) (2014 - 2022)
  • Table 30. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Geography (2014 - 2022)
  • Table 31. Global Active Pharmaceutical Ingredient Market, Market Size (%), By Major Regions (2014 - 2022)
  • Table 32. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion) (2014 - 2022)
  • Table 33. Active Pharmaceutical Ingredient Market in U.S, Market Size (US$ billion), (2014 - 2022)
  • Table 34. Active Pharmaceutical Ingredient Market in Canada, Market Size (US$ billion), (2014 - 2022)
  • Table 35. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Manufacturer (2014 - 2022)
  • Table 36. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Synthesis (2014 - 2022)
  • Table 37. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Drug Type (2014 - 2022)
  • Table 38. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Classification (2014 - 2022)
  • Table 39. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Therapeutic Area (2014 - 2022)
  • Table 40. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion)
  • Table 41. Active Pharmaceutical Ingredient Market in Germany, Market Size (US$ billion), (2014 - 2022)
  • Table 42. Active Pharmaceutical Ingredient Market in U.K, Market Size (US$ billion), (2014 - 2022)
  • Table 43. Active Pharmaceutical Ingredient Market in France, Market Size (US$ billion), (2014 - 2022)
  • Table 44. Active Pharmaceutical Ingredient Market in Italy, Market Size (US$ billion), (2014 - 2022)
  • Table 45. Active Pharmaceutical Ingredient Market in Rest of Europe, Market Size (US$ billion), (2014 - 2022)
  • Table 46. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Manufacturer (2014 - 2022)
  • Table 47. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Synthesis (2014 - 2022)
  • Table 48. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Drug Type (2014 - 2022)
  • Table 49. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Classification (2014 - 2022)
  • Table 50. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Synthesis (2014 - 2022)
  • Table 51. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion)
  • Table 52. Active Pharmaceutical Ingredient Market in China, Market Size (US$ billion), (2014 - 2022)
  • Table 53. Active Pharmaceutical Ingredient Market in India, Market Size (US$ billion), (2014 - 2022)
  • Table 54. Active Pharmaceutical Ingredient Market in Australia, Market Size (US$ billion), (2014 - 2022)
  • Table 55. Active Pharmaceutical Ingredient Market in Japan, Market Size (US$ billion), (2014 - 2022)
  • Table 56. Active Pharmaceutical Ingredient Market in Rest of Asia-Pacific, Market Size (US$ billion), (2014 - 2022)
  • Table 57. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Manufacturer (2014 - 2022)
  • Table 58. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Synthesis (2014 - 2022)
  • Table 59. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Drug Type (2014 - 2022)
  • Table 60. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Classification (2014 - 2022)
  • Table 61. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Therapeutic Area (2014 - 2022)
  • Table 62. Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion)(2014 - 2022)
  • Table 63. Active Pharmaceutical Ingredient Market in Latin America, Market Size (US$ billion), (2014 - 2022)
  • Table 64. Active Pharmaceutical Ingredient Market in Middle East & Africa, Market Size (US$ billion), (2014 - 2022)
  • Table 65. Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Manufacturer (2014 - 2022)
  • Table 66. Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Synthesis (2014 - 2022)
  • Table 67. Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Drug Type (2014 - 2022)
  • Table 68. Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Classification (2014 - 2022)
  • Table 69. Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Therapeutic Area (2014 - 2022)
  • Table 70. Active Pharmaceutical Ingredient Market, Snapshot
  • Table 71. Acronyms

LIST OF FIGURES

  • Figure 1. Research Methodology
  • Figure 2. Market Attractiveness forActive Pharmaceutical Ingredients Manufacturing Set-up
  • Figure 3. Global Active Pharmaceutical Ingredient Segment Share(%), By Manufacturer (2016& 2022)
  • Figure 4. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Manufacturer (2016 & 2022)
  • Figure 5. Global Captive API Market Size (US$ billion), By Regions (2016& 2022)
  • Figure 6. Global Merchant API Market Size (US$ billion), By Regions (2016& 2022)
  • Figure 7. Global Active Pharmaceutical Ingredient Market,Segment Share (%), By Synthesis (2016& 2022)
  • Figure 8. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Synthesis (2016 &2022)
  • Figure 9. Global Active Pharmaceutical Ingredient Market for Synthetic, Market Size (US$ billion) (2016& 2022)
  • Figure 10. Global Active Pharmaceutical Ingredient Market for Biological, Market Size (US$ billion) (2016& 2022)
  • Figure 11. Global Active Pharmaceutical Ingredient Market,Segment Share (%), By Drug Type (2016& 2022)
  • Figure 12. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Drug Type (2016 &2022)
  • Figure 13. Global Active Pharmaceutical Ingredient Market for Generics, Market Size (US$ billion) (2016& 2022)
  • Figure 14. Global Active Pharmaceutical Ingredient Market for Branded, Market Size (US$ billion) (2016& 2022)
  • Figure 15. Global Active Pharmaceutical Ingredient Market,Segment Share (%), By Classification (2016& 2022)
  • Figure 16. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Classification (2016 &2022)
  • Figure 17. Global HPAPI, Market Size (US$ billion) (2016& 2022)
  • Figure 18. Global Active Pharmaceutical Ingredient Market for Other Classification, Market Size (US$ billion) (2016& 2022)
  • Figure 19. Global Active Pharmaceutical Ingredient Market,Segment Share (%), By Therapeutic Area (2016& 2022)
  • Figure 20. Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Therapeutic Area (2016 &2022)
  • Figure 21. Global Active Pharmaceutical Ingredient Market for Cardiovascular Disorders, Market Size (US$ billion) (2016& 2022)
  • Figure 22. Global Active Pharmaceutical Ingredient Market for Metabolic Disorders, Market Size (US$ billion) (2016& 2022)
  • Figure 23. Global Active Pharmaceutical Ingredient Market for CNS, Market Size (US$ billion) (2016& 2022)
  • Figure 24. Global Active Pharmaceutical Ingredient Market for Oncology, Market Size (US$ billion) (2016& 2022)
  • Figure 25. Global Active Pharmaceutical Ingredient Market for Musculoskeletal Diseases, Market Size (US$ billion) (2016& 2022)
  • Figure 26. Global Active Pharmaceutical Ingredient Market for NSAIDs, Market Size (US$ billion) (2016& 2022)
  • Figure 27. Global Active Pharmaceutical Ingredient Market for Other Diseases, Market Size (US$ billion) (2016& 2022)
  • Figure 28. Global Active Pharmaceutical Ingredient Market, Segment Share (%), By Geography (2016& 2022)
  • Figure 29. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion)(2014 - 2022)
  • Figure 30. Active Pharmaceutical Ingredient Market in North America, Segment Share (%) By Regions, (2016 & 2022)
  • Figure 31. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Manufacturer, 2016 &2022
  • Figure 32. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion),By Synthesis (2016 &2022)
  • Figure 33. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion),By Drug Type (2016 &2022)
  • Figure 34. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion),By Classification (2016 &2022)
  • Figure 35. Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion),By Therapeutic Area (2016 &2022)
  • Figure 36. Active Pharmaceutical Ingredient Market in Europe; Market Size (US$ billion)(2014 - 2022)
  • Figure 37. Active Pharmaceutical Ingredient Market in Europe, Segment Share (%) By Regions, (2016 & 2022)
  • Figure 38. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion),By Manufacturer (2016 &2022)
  • Figure 39. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion),By Synthesis (2016 &2022)
  • Figure 40. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion),By Drug Type (2016 &2022)
  • Figure 41. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion),By Classification (2016 &2022)
  • Figure 42. Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion),By Therapeutic Area (2016 &2022)
  • Figure 43. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion)(2014 - 2022)
  • Figure 44. Active Pharmaceutical Ingredient Market in Asia-Pacific, Segment Share (%) By Regions, (2016 & 2022)
  • Figure 45. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion),By Manufacturer (2016 &2022)
  • Figure 46. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion),By Synthesis (2016 &2022)
  • Figure 47. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion),By Drug Type (2016 &2022)
  • Figure 48. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion),By Classification (2016 &2022)
  • Figure 49. Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion),By Therapeutic Area (2016 &2022)
  • Figure 50. Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion) (2014 - 2022)
  • Figure 51. Active Pharmaceutical Ingredient Market in Rest of the World, Segment Share (%) By Regions, (2016 & 2022)
  • Figure 52. Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion),By Manufacturer (2016 &2022)
  • Figure 53. Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion),By Synthesis (2016 &2022)
  • Figure 54. Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion),By Drug Type (2016 &2022)
  • Figure 55. Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion),By Classification (2016 &2022)
  • Figure 56. Active Pharmaceutical Ingredient Market in Rest of the World; Market Size (US$ billion),By Therapeutic Area (2016 &2022)
  • Figure 57. Market Positioning of Major Players (2015)